Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Mingyi Shang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5241-2686; OpenAlex author ID A5101800469. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 5

  1. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jcp.30346↗
  2. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis. Last author DOI 10.1002/jcb.29433↗
  3. PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation. Last author DOI 10.1111/jcmm.14896↗
  4. lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer. Co-author DOI 10.1016/j.omtn.2018.09.026↗
  5. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer. Co-author DOI 10.1093/abbs/gmw101↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aiwu Mao · 4 shared papers, 2016–2021 · strength 0.38
  2. Bingyan Liu · 3 shared papers, 2016–2021 · strength 0.30
  3. Bingyan Liu · 2 shared papers, 2018–2020 · strength 0.19
  4. Zhong-Min Wang · 1 shared paper, 2021 · strength 0.13
  5. Xiaoping Zou · 1 shared paper, 2021 · strength 0.13
  6. Rongkun Li · 1 shared paper, 2020 · strength 0.11
  7. Jun Ma · 1 shared paper, 2020 · strength 0.11
  8. Qing Li · 1 shared paper, 2020 · strength 0.11
  9. Li-Peng Hu · 1 shared paper, 2020 · strength 0.11
  10. Zhongmin Wang · 1 shared paper, 2020 · strength 0.11
  11. Lili Zhu · 1 shared paper, 2020 · strength 0.11
  12. Shu‐Heng Jiang · 1 shared paper, 2020 · strength 0.11
  13. Xianjun Sun · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.